Zogenix, Inc. (ZGNX): Price and Financial Metrics

ZGNX POWR Grades

• Growth is the dimension where ZGNX ranks best; there it ranks ahead of 66.37% of US stocks.
• ZGNX's strongest trending metric is Quality; it's been moving down over the last 177 days.
• ZGNX's current lowest rank is in the Stability metric (where it is better than 1.97% of US stocks).

ZGNX Stock Summary

• ZGNX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 132 -- higher than 82.6% of US-listed equities with positive expected earnings growth.
• ZGNX's price/sales ratio is 18.15; that's higher than the P/S ratio of 92.35% of US stocks.
• As for revenue growth, note that ZGNX's revenue has grown 498.77% over the past 12 months; that beats the revenue growth of 98.34% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Zogenix Inc, a group of peers worth examining would be KOPN, AIM, ACER, FORM, and GTHX.
• Visit ZGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.zogenix.com.

ZGNX Valuation Summary

• ZGNX's price/earnings ratio is -3.4; this is 109.32% lower than that of the median Healthcare stock.
• ZGNX's price/sales ratio has moved up 10.7 over the prior 130 months.
• Over the past 130 months, ZGNX's EV/EBIT ratio has gone down 1.

Below are key valuation metrics over time for ZGNX.

ZGNX Growth Metrics

Its 5 year price growth rate is now at 174.21%.
• The year over year net income to common stockholders growth rate now stands at 41.67%.
• Its 4 year price growth rate is now at 174.21%.

ZGNX's revenue has moved up $31,811,000 over the prior 67 months.

The table below shows ZGNX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	63.585	-182.325	-242.7
2021-06-30	43.835	-180.539	-244.785
2021-03-31	26.078	-168.898	-239.213
2020-12-31	13.643	-167.531	-209.383
2020-09-30	7.09	-164.017	-195.273
2020-06-30	4.86	-153.562	-425.662

ZGNX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ZGNX has a Quality Grade of C, ranking ahead of 60.76% of graded US stocks.
• ZGNX's asset turnover comes in at 0.071 -- ranking 291st of 681 Pharmaceutical Products stocks.
• ARMP, BTX, and PRTK are the stocks whose asset turnover ratios are most correlated with ZGNX.

The table below shows ZGNX's key quality metrics over time.